Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Tomasz Brzoska on How Personalized Medicine Benefits SCD Patients
Jan 16, 2026, 19:12

Tomasz Brzoska on How Personalized Medicine Benefits SCD Patients

Tomasz Brzoska, Assistant Professor of Medicine in University of Pittsburgh, School of Medicine, shared on LinkedIn:

”Our newest study has just been published.

See how personalized medicine can potentially benefit sickle cell disease patients!

Big thanks to all collaborators and contributors, especially Prithu Sundd, PhD , PhD and Tomasz Kaminski.

Most of the studies were performed at University of Pittsburgh School of Medicine and Vascular Medicine Institute.”

Read the full article here.

Article: CD39 polymorphism enables lung thrombosis in sickle cell disease

Authors: Tomasz Brzoska, Tomasz W. Kaminski, Omika Katoch, Elizaveta V. Menchikova, Adekunle E. Alagbe, Sarah E. Tashbook, Stevan P. Tofovic, Jude C. Jonassaint, Claudette M. St. Croix, Simon C. Watkins, Shane Howe, Joshua J. Field, Amanda A. Seyerle, Tirthadipa Pradhan-Sundd, Cecilia Laurie, Nathan D. Pankratz, Nicholas L. Smith, Ellen L. Goode, James S. Pankow, Charles Kooperberg, Gregory J. Kato, Yingze Zhang, Enrico M. Novelli, Mark T. Gladwin, Edwin K. Jackson, Seyed M. Nouraie, Prithu Sundd

Tomasz Brzoska on How Personalized Medicine Benefits SCD Patients

Stay updated on all scientific advances with Hemostasis Today.